Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

  title={Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.},
  author={Ronald C. Kessler and Katherine A. McGonagle and S. Zhao and Christopher B. Nelson and M Hughes and Suzann Eshleman and Hans-Ulrich Wittchen and Kenneth S. Kendler},
  journal={Archives of general psychiatry},
  volume={51 1},
BACKGROUND This study presents estimates of lifetime and 12-month prevalence of 14 DSM-III-R psychiatric disorders from the National Comorbidity Survey, the first survey to administer a structured psychiatric interview to a national probability sample in the United States. [] Key MethodRESULTS Nearly 50% of respondents reported at least one lifetime disorder, and close to 30% reported at least one 12-month disorder.
Lifetime and 12-month prevalence of DSM-III-R disorders in the Chile psychiatric prevalence study.
The prevalence rates in Chile are similar to those obtained in other studies conducted in Latin America and Spanish-speaking North American groups, however, comorbidity and alcohol use disorders were not as prevalent as in North America.
DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.
Although lifetime GAD is highly comorbid, the proportion of current GAD that is not accompanied by any other current diagnosis is high enough to indicate that GAD should be considered an independent disorder rather than exclusively a residual or prodrome of other disorders.
Lifetime and 6-month prevalence of DSM-III-R psychiatric disorders in an urban community in Japan
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.
Although mental disorders are widespread, serious cases are concentrated among a relatively small proportion of cases with high comorbidity, as shown in the recently completed US National Comorbidities Survey Replication.
Comorbidity of DSM–III–R Major Depressive Disorder in the General Population: Results from the US National Comorbidity Survey
The analysis shows that most cases of lifetime MDD are secondary, in the sense that they occur in people with a prior history of another DSM-III-R disorder, which is more persistent and severe than pure or primary MDD.
Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey
The results show that while psychiatric disorders are common in the Mexican population, very severe mental disorders are less common and there is extreme under-utilization of mental health services.
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.
Lifetime prevalence estimates are higher in recent cohorts than in earlier cohorts and have fairly stable intercohort differences across the life course that vary in substantively plausible ways among sociodemographic subgroups.
Psychiatric disorders in Mexico: Lifetime prevalence in a nationally representative sample
The results suggest an urgent need to re-evaluate the resources allocated for the detection and treatment of psychiatric illnesses in Mexico and suggest younger cohorts are at greater risk for most disorders.
Lifetime and 12-month prevalence, severity and unmet need for treatment of common mental disorders in Japan: results from the final dataset of World Mental Health Japan Survey
The results suggest lower prevalence of mental disorders in Japan than that in Western countries, although the general pattern of disorders, risk factors and unmet need for treatment were similar to those in other countries.
Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey.
The results show that alcohol abuse and dependence are often associated with other lifetime NCS/DSM-III-R disorders and suggest that, at least in recent cohorts, the alcohol use disorders are usually temporally secondary.


Estimating the prevalence of mental disorders in U.S. adults from the Epidemiologic Catchment Area Survey.
The National Institute of Mental Health Epidemiologic Catchment Area Survey is a comprehensive, community-based survey of mental disorders and use of services by adults, ages 18 and older, and the population with disorders is estimated.
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.
Comorbidity of addictive and severe mental disorders was highest in the prison population, most notably with antisocial personality, schizophrenia, and bipolar disorders.
Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore.
This work should produce a more complete understanding of obstacles to mental disorder case ascertainment by lay interview and clinical examination methods in the context of a field survey.
Lifetime prevalence of specific psychiatric disorders in three sites.
Lifetime rates are presented for 15 DSM-III psychiatric diagnoses evaluated in three large household samples on the basis of lay interviewers' use of the Diagnostic Interview Schedule. The most
The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.
Potential 1-year prevalence and service use rates of mental and addictive disorders in the US population and applications to US health care system reform options are considered in the context of other variables that will determine national health policy.
Christchurch Psychiatric Epidemiology Study, Part I: Methodology and Lifetime Prevalence for Specific Psychiatric Disorders
Compared with results from the Epidemiologic Catchment Area Program, Puerto Rico and Edmonton, Christchurch has the highest rates for major depression and is among the highest for alcohol abuse/dependence.
Comorbidity of Mental Disorders and Substance Use Disorders
Comorbidity rates between specific substance use disorders and other mental disorders will be compared and discussed in light of several other international epidemiological studies.
Recall and dating of psychiatric symptoms. Test-retest reliability of time-related symptom questions in a standardized psychiatric interview.
Data from two independent test-retest studies of the Diagnostic Interview Schedule (DIS and CIDI) was used to study the reliability of different time-related questions in these fully standardized diagnostic interviews and found a surprisingly high concordance for former psychotic patients except for those still severely disturbed at the follow-up investigation.
Psychoactive drug use in a general population sample, Sweden: correlates with perceived health, psychiatric diagnoses, and mortality in an automated record-linkage study.
  • C. Allgulander
  • Psychology, Medicine
    American journal of public health
  • 1989
Among those admitted for inpatient psychiatric care, substance abuse was an infrequent diagnosis; the majority of schizophrenics and of those with an affective disorder appeared not to medicate regularly; survey non-responders had higher rates of mental disorders than responders.
The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.
A test-retest reliability study of the Structured Clinical Interview for DSM-III-R was conducted on 592 subjects in four patient and two nonpatient sites in this country as well as one patient site